T80.411D Rh incompatibility with delayed hemolytic transfusion reaction, subsequent encounter

Name of the Condition

• Rh incompatibility with delayed hemolytic transfusion reaction, subsequent encounter.

Summary

This condition describes an immune-mediated hemolytic reaction occurring when Rh-negative individuals receive Rh-positive blood or blood products, leading to delayed destruction of red blood cells (hemolysis). It results from the recipient’s immune system recognizing Rh antigens as foreign, triggering antibody production and subsequent hemolysis. The "subsequent encounter" classification indicates the reaction is being managed after an initial acute phase.

Causes

The reaction is triggered by the presence of Rh-positive red blood cells in an Rh-negative recipient, which the immune system identifies as foreign. This initiates antibody production, causing hemolysis. Transfusions of whole blood, packed red blood cells, or plasma products containing Rh-positive cells are common sources. The delayed nature suggests a pre-existing antibody response from prior exposure.

Risk Factors

• Rh-negative blood type
• Prior exposure to Rh-positive blood (e.g., previous transfusions or pregnancy)
• Inadequate crossmatching or typing before transfusion
• Use of blood products with unknown Rh status

Symptoms

• Fever, chills, or rigors
• Jaundice or dark urine (hemoglobinuria)
• Anemia-related fatigue or pallor
• Shortness of breath or tachycardia
• Abdominal or back pain
• Elevated bilirubin levels (laboratory finding)

Diagnosis

Diagnosis involves confirming Rh incompatibility through blood typing and crossmatching, along with clinical assessment of transfusion history. Laboratory tests may show evidence of hemolysis, such as elevated bilirubin or decreased haptoglobin. The delayed onset distinguishes this from acute reactions.

Treatment Options

Treatment focuses on managing hemolysis and preventing further complications. This may include supportive care, such as hydration and monitoring for renal function. In severe cases, additional transfusions with Rh-negative blood or immunosuppressive therapy may be considered.

Prognosis and Follow-Up

Prognosis is generally favorable with appropriate management, though complications like renal impairment can occur. Follow-up care involves monitoring for recurrence and ensuring Rh-negative blood is used in future transfusions to prevent further reactions.

Complications

• Acute kidney injury
• Severe anemia
• Disseminated intravascular coagulation (DIC)
• Transfusion-related acute lung injury (TRALI)

Lifestyle & Prevention

Prevention involves thorough blood typing and crossmatching before transfusions. Rh-negative individuals should receive Rh-negative blood products whenever possible. Avoiding unnecessary transfusions and ensuring proper documentation of blood type history can reduce risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, jaundice, or dark urine occur after a transfusion, as these may indicate a delayed hemolytic reaction. Prompt evaluation is critical to prevent complications.

Tips for Medical Coders

This code is used for a subsequent encounter of Rh incompatibility with delayed hemolytic transfusion reaction. Documentation should specify the encounter type (subsequent) and confirm the delayed nature of the reaction. Ensure the diagnosis aligns with clinical findings and transfusion history.